Table 3 Distribution characteristics of ThyPRO score at baseline
Scales, n = 47 observations | No. of items | Mean (SD) | Median (Interquartile range) | Min - Max range | Floor/ Ceiling (%) | Cronbach’s alpha |
|---|---|---|---|---|---|---|
ThyPRO Original, Baseline | ||||||
Goitre Symptoms | 11 | 12 (13) | 7 (2–20) | 0–45 | 20/0 | 0.81 |
Hyperthyroid Symptoms | 8 | 37 (25) | 34 (19–67) | 0–78 | 4/0 | 0.87 |
Hypothyroid Symptoms | 4 | 24 (24) | 19 (6–27) | 0–100 | 17/ 2 | 0.75 |
Eye Symptoms | 8 | 15 (18) | 7 (0–28) | 0–75 | 33/0 | 0.87 |
Tiredness | 7 | 50 (24) | 52 (32–64) | 0–100 | 2/4 | 0.85 |
Cognitive Complaints | 6 | 23 (28) | 13 (0–42) | 0–100 | 31/4 | 0.95 |
Anxiety | 6 | 30 (26) | 25 (8–46) | 0–100 | 17/2 | 0.91 |
Depressivity | 7 | 29 (24) | 29 (11–39) | 0–100 | 10/2 | 0.91 |
Emotional Susceptibility | 9 | 37 (21) | 32 (22–53) | 3–100 | 0/2 | 0.89 |
Impact on Social life | 4 | 18 (21) | 13 (0–25) | 0–100 | 25/2 | 0.79 |
Impact on Daily life | 6 | 20 (26) | 8 (0–42) | 0–100 | 40/ 2 | 0.93 |
Impact on Sex life | 2 | 18 (30) | 0 (0–25) | 0–100 | 60/ 6 | 0.98 |
Cosmetic Complaints | 6 | 20 (25) | 8 (0–30) | 0–96 | 25/ 0 | 0.85 |
Overall QOL Impact | 1 | 33 (34) | 25 (0–50) | 0–100 | 31/13 | – |